Smartleaf Asset Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.78K Hold
195
﹤0.01% 2419
2026
Q1
$4.75K Sell
195
-333
-63% -$7.88K ﹤0.01% 2678
2025
Q4
$13.2K Sell
528
-47
-8% -$1.25K ﹤0.01% 2257
2025
Q3
$16.7K Buy
575
+136
+31% +$3.69K ﹤0.01% 1880
2025
Q2
$10.9K Sell
439
-28
-6% -$789 ﹤0.01% 1806
2025
Q1
$14.3K Sell
467
-172
-27% -$5.73K ﹤0.01% 1777
2024
Q4
$20.4K Buy
639
+485
+315% +$23K ﹤0.01% 1626
2024
Q3
$8.71K Buy
154
+40
+35% +$1.97K ﹤0.01% 1842
2024
Q2
$4.65K Buy
114
+24
+27% +$952 ﹤0.01% 1845
2024
Q1
$3.7K Buy
+90
New +$3.51K ﹤0.01% 1318

Other funds holding ASTH

Smartleaf Asset Management's ASTH Position: Q2 2026 in Review

Smartleaf Asset Management held its Astrana Health (ASTH) position steady in Q2 2026 at 195 shares worth $8.78K. The position accounts for ﹤0.01% of the portfolio, ranked #2419.

Smartleaf Asset Management first reported a position in ASTH in Q1 2024 and has held it in 10 quarters since. The position peaked at $20.4K in Q4 2024. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Smartleaf Asset Management held 195 shares of Astrana Health worth $8.78K as of Q2 2026.
  • Smartleaf Asset Management left its Astrana Health share count unchanged in Q2 2026.
  • Astrana Health made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2419 holding.
  • Smartleaf Asset Management first reported a position in Astrana Health in Q1 2024 and has held it in 10 quarters since.
  • Smartleaf Asset Management's Astrana Health position peaked at $20.4K in Q4 2024.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.